The mechanism of action of artemisinin appears to involve two steps. In the first step, activation, intra-parasitic iron catalyses the cleavage of the endoperoxide bridge and the generation of free radicals. In the second step, alkylation, the artemisinin-derived free radical forms covalent bonds with parasite proteins.
Introduction
Several classes of compounds containing endoperoxide (dioxygen) bridges have antimalarial activity, including artemisinin derivatives (reviewed by BUTLER & Wu, 1992) , trioxanes (reviewed by JEFFORD et al., 1992) , and yingzhaosu derivatives (R. Ridley, Hoffman-LaRoche, personal wmmunication) (Fig. 1) . The best understood A"em,~m,n Y,ngzhaoor"
Fig. 1. Antimalarial endoperoxides
Trloxans of these compounds, in terms of mechanism, are the artemisinin derivatives. In this report, evidence is summarized to show that the antimalarial action of artemisinin (and, by inference, other endoperoxides) depends on 2 sequential steps. The first step, activation, comprises the iron-mediated cleavage of the endoperoxtde bridge m generate an unstable organic free radical and/or other electrophilic species. The second step, alkylation, involves the formation of covalent adducts between the drug and malarial proteins (Fig. 2) . Fig. 2 . Proposed mechanism of action af arremwun. Activation A free radical is a short-lived and highly reactive molecule that contains an unpaired electron. While many of the biologically im rtant free radicals are partially reduced forms of mo ecular oxygen (Oz-, HO,), evidence p" is accumulating in a number of systems that carboncentred free radicals play important roles (HALLIWELL & GUTTERIDGE, 1989) .
Iron has long been known m catalyse the decomposition of both hydrogen peroxide and organic peroxides into free radicals. This catalytic activity is a property of both free iron and haem-bound iron (HALLIWELL & GUTTERIDGE, 1989) . With this as background, the observation that deoxyartemisinin, which lacks the endoperoxide bridge, has no antimalarial activity (CO-OPERA-TIVE RESEARCH GROUP ON Q~NGHAOSU AND IT.S DERJVATIVES AS ANTIMALARIAL& 1982) led my colleagues and I to investigate whether iron-catalysed cleavage of the endoperoxide bridge might play a role in the drug's mechanism of action.
Indeed, iron readily catalyses the cleavage of artemisinin's endoperoxide bridge. Evidence for the haem-catalysed decomposition of artemisinin was obtained by cyclic voltammetty (ZHANG er al., 1992) . At least one of the products of the iron-mediated decomposition is a free radical, which was demonstrated by electron aramanetic resonance spectroscopy P f Haem also catalyses the generation of radicals from artemisinin (F. Kuypers, unpublished results). The mecharism of iron-mediated decomposition has recently been elucidated (POSNER & OH, 1992) . In aggregate, these data indicate that iron activates artemisinin into a free radical.
There is stron d evidence that the antimalarial activities of these drugs epend on the generation of free radical intermediates. Free radical scavengers such as ascorbic acid and vitamin E antagonize the antimalarial activities of the drug both in vitro (KRUNGKRAI & YUTHAVONG, 1987; MESHNICK et al., 1989) and in viva (LWANDER et al., 1989) . However, the free radical intermediate, once formed, may structurally rearrange to produce other reactive and electrophilic intermediates (POSNER & OH, 1992) .
Drue activation bv iron and haem tnav exolain whv endop&xides are s&ctively toxic to m&ia'parasit& Malaria parasites live in a 'sea' of haem-iron (the red cell is 95% haemaglobin, or 20 rn~ haem), which they eventually convert into insoluble haemozin. The observation that chloroouine-resistant Plasmodium bewkez, which lacks visibl; haemozoin. is resistant to -art&nisinin (PETERS et al., 1986) suggests that active haemozoin biosvnthesis is essential for drue activitv.
' There are several different iron &~ls in the infected red blood cell which might be responsible for drug activation (Fig. 2) . In the food vacuole, haemoglobin is in the process of being broken down, releasing haem. The haem, in turn is in the process of being polymerized into haemozoin. There may also be free iron formed (H. Ginsburg, Hebrew University, personal communication). Fmally, there are haemoproteins (i.e., cytochromes) in the mitochondria. Which of these iron pools is responsible for catalysing the decomposition of artemisinin *n vtuo? In vitro, artemisinin reacts poorly or not at all when mixed with either haemoglobin or haemozoin, suggesting that these pools may not be important. In contrast, artemisinin is activated suite well bv haem and free iron (MESHNICK et al., lhl, 1993; ~'OSNER et al., 1992; ZHANG et al., 1992) . The observation that chloraquine, which binds haem (CHOU et al., 1980) , antagonizes the antimalarial activity of artemisinin against P. falcipancm (see STAHEL et& 1988) suggests that the free haem pool may be important. Similarly, the observation that iron chelators, which bind free iron, are antagonistic, suggests that free iron may be important (KAMCHONWONGPAISAN et al., 1992; MESHNICK et al., 1993) . However, smne iron chelators also bind haem. Thus, it appears that the transient pools of haem and free iron may be responsible for activating artemisinin m ozw.
Alkylation
After the drug is converted 10 a reactive free radical it can then form covalent bonds with proteins. The reac-S1132 tions of both [tQwtemisinin and [~H] dihydroattemisinin with proteins have been studied m 2 model systerns-hun&n serum and isolated red cell membranes. Radiolabelled artemisinin covalently reacts with human serum albumin in a time-dependent fashion, predominantly forming bonds with free amino groups . There are both iron-dependent and iron-independent reactions. The covalent nature of the adduct was demonstrated by sodium dodecyl sulphatepolyacrylamide gel electrophoresis and by electrospray mass spectrometry . Radiolabelled drug is also taken up by isolated red cell membranes, where it forms covalent bonds with various membrane proteins such as wspectrin, P-spectrin, band 3, band 4.1,4,2, actin and glyceraldehyde phosphate dehydrogenase. In contrast, when artemisinin is incubated with mtact erythrocytes, there is no uptake or protein alkylation iW. Asawamahasakda et al.. tu.~er submitted for mtblisubmitted for publication).
Once taken into the parasite, [3H]dihydroartemisinin concentrates in the haemozoin. In addition, several malaria-specific proteins are alkylated (W. Asawamahasakda et al., paper submitted for publication).
Other effects of artemisinin
Electron microgra hs have demonstrated that the earliest pathological e f? ects of artemisinin are on parasite membranes and mitochondria, as well as on food vacuoles (MAENO et al., 1993) . The effects on membranes and mitochondria may be secondary to the toxic effects of the drug on the food vacuole, or they may be due to activation and alkylation reactions occurring at those sites.
Very high concentrations of artemisinin (0.1-I mht) cause oxidation of red blood cell membrane proteins and decreases in red cell deformability, especially in the presence of exogenous haem (SCOTT et al., 1989; MESN-NICK et al., 1991 , suggesting that the drug may affect plasma membrane fimcuon in infected erythtocytes. However, no such effect has been seen at therapeutic drug concentrations.
Effects of endoperoxides
on the host The mechanisms described above may also explain some of the drug's effects on the host (BREWER et al., 1992) . Iron-mediated activation of endoperoxides may play a role in host toxicity since an iron chelator has been shown to prolong survival in mice given lethal doses of artemisinin . In addition, the facile reactions between artemisinin and host proteins may play a role in the rapid disappearance of the drug from the blood-stream.
Summary
The endoperoxides represent a new class of antimalarial agents, which are entirely unrelated to any of the other currently available drugs. Insight into their mechanisms of action can aid in the design of new and more effective derivatives.
